[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2004056964A3 - Vecteurs pour l'interference arn inductible - Google Patents

Vecteurs pour l'interference arn inductible Download PDF

Info

Publication number
WO2004056964A3
WO2004056964A3 PCT/US2003/040548 US0340548W WO2004056964A3 WO 2004056964 A3 WO2004056964 A3 WO 2004056964A3 US 0340548 W US0340548 W US 0340548W WO 2004056964 A3 WO2004056964 A3 WO 2004056964A3
Authority
WO
WIPO (PCT)
Prior art keywords
vectors
rna interference
inducible rna
inducible
interfere
Prior art date
Application number
PCT/US2003/040548
Other languages
English (en)
Other versions
WO2004056964A2 (fr
Inventor
William Winston
Ronan C O'hagan
Joerg Heyer
William Rideout
Bijan Etemad-Moghadam
Original Assignee
Genpath Pharmaceuticals Inc
William Winston
Ronan C O'hagan
Joerg Heyer
William Rideout
Bijan Etemad-Moghadam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genpath Pharmaceuticals Inc, William Winston, Ronan C O'hagan, Joerg Heyer, William Rideout, Bijan Etemad-Moghadam filed Critical Genpath Pharmaceuticals Inc
Priority to AU2003299732A priority Critical patent/AU2003299732A1/en
Publication of WO2004056964A2 publication Critical patent/WO2004056964A2/fr
Publication of WO2004056964A3 publication Critical patent/WO2004056964A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des vecteurs de recombinaison pour l'expression par induction de molécules d'ARN bicaténaire qui interfèrent avec l'expression d'un gène cible.
PCT/US2003/040548 2002-12-18 2003-12-18 Vecteurs pour l'interference arn inductible WO2004056964A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003299732A AU2003299732A1 (en) 2002-12-18 2003-12-18 Vectors for inducible rna interference

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43485602P 2002-12-18 2002-12-18
US60/434,856 2002-12-18
US49931303P 2003-08-28 2003-08-28
US60/499,313 2003-08-28

Publications (2)

Publication Number Publication Date
WO2004056964A2 WO2004056964A2 (fr) 2004-07-08
WO2004056964A3 true WO2004056964A3 (fr) 2004-10-14

Family

ID=32685340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/040548 WO2004056964A2 (fr) 2002-12-18 2003-12-18 Vecteurs pour l'interference arn inductible

Country Status (2)

Country Link
AU (1) AU2003299732A1 (fr)
WO (1) WO2004056964A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065613A2 (fr) * 2003-01-17 2004-08-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Constructions geniques permettant l'expression inductible de petites molecules d'arn pour une extinction genique ciblee
FR2877674A1 (fr) * 2004-11-08 2006-05-12 Genoxay Sa Animaux modeles comprenant au moins un transgene et une sequence permettant l'expression controlee d'un rna interferant avec ledit transgene
US7691989B2 (en) * 2004-12-22 2010-04-06 Genentech, Inc. Methods for producing soluble membrane-spanning proteins
WO2006131543A1 (fr) * 2005-06-09 2006-12-14 Artemis Pharmaceuticals Gmbh Expression d'arnsh et d'arnsi dans un organisme vivant sous controle d'un gene represseur de la tetracycline optimise par un codon
EP1731607A1 (fr) * 2005-06-09 2006-12-13 ARTEMIS Pharmaceuticals GmbH Expression au sein d'un organisme vivant de shRNA et siRNA sous le contrôle d'un gène represseur de tétracycline à codons optimisés
US20080220471A1 (en) * 2005-07-27 2008-09-11 Genentech, Inc. Vectors and Methods Using Same
US20070113295A1 (en) * 2005-09-23 2007-05-17 California Institute Of Technology Gene blocking method
GB0602173D0 (en) 2006-02-03 2006-03-15 Avecia Ltd Expression system
EP3219799A1 (fr) * 2016-03-17 2017-09-20 IMBA-Institut für Molekulare Biotechnologie GmbH Expression sgrna crispr conditionnelle
CN110540995B (zh) * 2018-05-28 2023-01-10 南京农业大学 一种降低肌球蛋白-5蛋白及其在氰基丙烯酸酯类药物抗性治理中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917122A (en) * 1992-08-26 1999-06-29 Byrne; Guerard Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice
US20040002077A1 (en) * 2001-11-28 2004-01-01 Center For Advanced Science And Technology Incubation, Ltd. siRNA expression system and method for producing functional gene knock-down cell using the system
US20040005593A1 (en) * 2002-03-06 2004-01-08 Rigel Pharmaceuticals, Inc. Novel method for delivery and intracellular synthesis of siRNA molecules
US20040115815A1 (en) * 2002-07-24 2004-06-17 Immusol, Inc. Single promoter system for making siRNA expression cassettes and expression libraries using a polymerase primer hairpin linker

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917122A (en) * 1992-08-26 1999-06-29 Byrne; Guerard Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic mice
US20040002077A1 (en) * 2001-11-28 2004-01-01 Center For Advanced Science And Technology Incubation, Ltd. siRNA expression system and method for producing functional gene knock-down cell using the system
US20040005593A1 (en) * 2002-03-06 2004-01-08 Rigel Pharmaceuticals, Inc. Novel method for delivery and intracellular synthesis of siRNA molecules
US20040115815A1 (en) * 2002-07-24 2004-06-17 Immusol, Inc. Single promoter system for making siRNA expression cassettes and expression libraries using a polymerase primer hairpin linker

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CZAUDERNA FRANK; ET AL: "Inducible shRNA expression for application in a prostate cancer mouse model", NUCLEIC ACIDS RESEARCH, vol. 31, no. 21, 1 November 2003 (2003-11-01), pages E127-1 - E127-7, XP002291076 *
ELBASHIR S.M. ET AL: "Analysis of gene function in somatic mammalian cells using small interfering RNAs", METHODS, vol. 26, no. 2, February 2002 (2002-02-01), pages 199 - 213, XP002251055 *
HANNON G.J.: "RNA interference", NATURE, vol. 418, 11 July 2002 (2002-07-11), pages 244 - 251, XP002979088 *
HASUWA H. ET AL: "Small interfering RNA and gene silencing in transgenic mice and rats", FEBS LETTERS, vol. 532, 13 November 2002 (2002-11-13), pages 227 - 230, XP004395375 *
OGUETA ET AL: "Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector", MOLECULAR MEDICINE, vol. 7, no. 8, August 2001 (2001-08-01), pages 569 - 579, XP002960124 *
OHKAWA ET AL: "Control of the functional activity of an antisense RNA by a tetracyclin-responsive derivative of the human U6 snRNA promoter", HUMAN GENE THERAPY, vol. 11, no. 4, 1 March 2000 (2000-03-01), pages 577 - 585, XP000926522 *
SASAKI ET AL: "A system for conditional RNA interference in the mouse using the lac operator - repressor system", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol. 2003, no. ABSTRACT NO. 325.4, 8 November 2003 (2003-11-08), XP002979518 *
SUI ET AL: "A DNA vector-based RNAi technology to suppress gene expression in mammalian cells", PNAS, vol. 99, no. 8, 16 April 2002 (2002-04-16), pages 5515 - 5520, XP002964701 *

Also Published As

Publication number Publication date
WO2004056964A2 (fr) 2004-07-08
AU2003299732A1 (en) 2004-07-14
AU2003299732A8 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
WO2004081167A3 (fr) Vecteurs d'expression comprenant le promoteur de mcmv ie2
WO2007000668A3 (fr) Vecteur de genes
WO2003093441A3 (fr) Procede de regulation de l'expression genique
EP2305812A3 (fr) SIRNA fonctionnel et hyperfonctionnel
WO2001019981A3 (fr) Genomique fonctionnelle utilisant des proteines a doigts de zinc
WO2003093793A3 (fr) Procede et systeme de ciblage a composants multiples
AU2003229294A1 (en) Cancer-linked gene as target for chemotherapy
EP1575492A3 (fr) Gene lie au cancer comme cible de chimiotherapie
EP1576111A3 (fr) Gene lie au cancer servant de cible en chimiotherapie
AU2003249691A1 (en) Cancer-linked gene as target for chemotherapy
AU2003239969A1 (en) Cancer-linked gene as target for chemotherapy
WO2007058527A3 (fr) Systemes d’expression inductible
WO2005052143A3 (fr) Adenovirus, acides nucleiques les codant et utilisations associees
WO2004056964A3 (fr) Vecteurs pour l'interference arn inductible
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2007041350A3 (fr) Promoteurs de fusion regulables
WO2005087932A3 (fr) Vecteurs pour le clonage directionnel
WO2003034985A3 (fr) Interference par telomerase
WO2000058352A3 (fr) Gene d'orge pour reductase de thioredoxine et de thioredoxine nadp
WO2004020640A3 (fr) Cassettes d'expression procaryotes regulees par le zinc
WO2003033692A3 (fr) Utilisation du promoteur tardif e2 adenoviral
AU2003220146A1 (en) Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof
AU2003288785A1 (en) Plasmid having a function of t-vector and expression vector, and expression of the target gene using the same
AU2001282084A1 (en) Nucleotide sequences which code for the sigh gene
WO2005052168A3 (fr) Systeme d’expression inductible de proteines recombinantes chez les cyanobacteries

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP